News — Healthcare & Biotech

Sector Focus

News overview Healthcare & Biotech

Premium selection of analyses, tops and drops to understand the dynamics of the Healthcare & Biotech sector at a glance.

Explore sector Search for a stock

Healthcare & Biotech

Medline Expands Texas Logistics Network

Medline Inc (NASDAQ: MDLN) announced a major expansion with a new 1.2 million sq ft distribution center in Midlothian, Texas, scheduled to be operational by Q2 2027. This move strengthens Medline's growth strategy following its late 2025 IPO. Despite a recent 10% dip over the past month, the stock maintains a positive annual trend, reflecting sustained inves…

Published 2 weeks ago MDLN 44.28 · 0.64 % expansion• logistics• secondary offering

Abivax rocked by AstraZeneca buyout rumors despite denial

At the end of March 2026, Abivax shares reacted to speculation about an exclusivity period granted to AstraZeneca for a possible takeover bid. However, Abivax's official denial cooled enthusiasm, main...

ABVX 3 weeks ago

101.40 0.59 %

Ralliant Posts Strong Growth Despite Barclays Cut

Ralliant Corporation reported a 1% revenue increase in Q4 2025, surpassing expectations thanks to a robust 29% growth in its Communications segment. Despite this strong performance, Barclays lowered i...

RAL 1 month ago

42.00 1.41 %

Hinge Health Lowers Targets but Upside Potential Stays

Hinge Health (NYSE: HNGE) has seen its price targets cut by several analysts, with KeyBanc lowering its target from $70 to $55 while maintaining an "overweight" rating. Similarly, Evercore ISI trimmed...

HNGE 1 month ago

39.26 2.24 %

Sanofi faces Dupixent patent expiry in 2031

The article highlights growing concern among Sanofi executives as 2031 approaches, the year the patent protecting the flagship drug Dupixent will expire. This milestone could weaken the group's growth...

SAN 1 month ago

82.58 0.35 %

Continuous feed

The latest updates, in real time.

20 updates

Sanofi Completes Acquisition of Dynavax

Healthcare & Biotech SAN

82.58 0.35 %

Sanofi Boosts Profitability with Dupixent Despite Stock Drop

Healthcare & Biotech SAN

82.58 0.35 %

J.P. Morgan Chase Exceeds 10% Stake in DBV Technologies

Healthcare & Biotech DBV

3.63 3.07 %

CARMAT Enters Judicial Recovery, Seeks Investors

Healthcare & Biotech ALCAR

0.10 –

Abivax falls as buyout hopes fade

Healthcare & Biotech ABVX

101.40 0.59 %

Ikonisys Raises €2.72M via Capital Raise and Debt Conversion

Healthcare & Biotech ALIKO

1.52 –

Genfit Reports Q3 2025 Results, Exits US Nasdaq

Healthcare & Biotech GNFT

6.27 1.29 %

Oncodesign Ends Collaboration with Navigo Proteins

Healthcare & Biotech ALOPM

0.48 1.68 %

GenSight Biologics Strengthens Funding and Regulatory Status

Healthcare & Biotech SIGHT

0.09 2.08 %

ProShares RXL announces share buybacks in August 2025

Healthcare & Biotech RXL

45.94 1.52 %

Valneva Restructures, Regains Control of Chikungunya Vaccine

Healthcare & Biotech VLA

2.71 3.97 %

Nanobiotix Joins CAC Mid 60 and SBF 120 on Euronext Paris

Healthcare & Biotech NANO

27.40 5.35 %

Insider Sell-Off at Sionna Therapeutics Raises Concerns

Healthcare & Biotech SION

40.49 1.96 %

NicOx boosts cash and plans NCX 470 filing in 2026

Healthcare & Biotech ALCOX

0.41 0.49 %

Sanofi to acquire Dynavax for $2.2 billion

Healthcare & Biotech DVAX

15.50 0.06 %

WORK Medical announces 1-for-100 stock consolidation

Healthcare & Biotech WOK

1.20 2.56 %

Abivax Draws Big Pharma Interest on Promising Data

Healthcare & Biotech ABVX

101.40 0.59 %

Medincell posts strong H1 results, preps Olanzapine LAI launch

Healthcare & Biotech MEDCL

23.10 0.69 %

Bayer rallies on restructuring and medical advances

Healthcare & Biotech BAYN

38.38 0.21 %

Bayer Soars After US Supreme Court Backs Roundup Review

Healthcare & Biotech BAYN

38.38 0.21 %